Brief: Cortexyme Corporate Name Change To Quince Therapeutics To Take Effect On August 1, 2022
Cortexyme Inc CRTX.O :
* CORTEXYME CORPORATE NAME CHANGE TO QUINCE THERAPEUTICS TO
TAKE
EFFECT ON AUGUST 1, 2022
* CORTEXYME - TICKER SYMBOL ON NASDAQ GLOBAL SELECT MARKET
IS
EXPECTED CHANGE TO "QNCX" EFFECTIVE AT OPEN OF MARKET TRADING ON
MONDAY, AUGUST 1, 2022
Source text for Eikon: ID:nBwbXD5Jga
Further company coverage: CRTX.O
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges